8 Results for "

COH

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "COH" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-19931
CAS No.: 1190932-38-7
Synonyms: RNR Inhibitor COH29
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

COH29 (RNR Inhibitor COH29) is a potent ribonucleotide reductase (RNR) inhibitor with anticancer activity. COH29 inhibits α and β subunit of RNR with IC50s of 16 μM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-128760
CAS No.: 906439-72-3
Purity:  99.92%
Research Areas:  

Cancer

COH34 is a potent and specific poly(ADP-ribose) glycohydrolase (PARG) inhibitor with an IC50 of 0.37 nM. COH34 binds to the catalytic domain of PARG (Kd=0.547 μM), thereby prolonging PARylation at DNA lesions and trapping DNA repair factors .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114304
CAS No.: 1534358-79-6
Purity:  ≥98.0%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

COH000 is an allosteric, covalent and irreversible inhibitor of ubiquitin-like 1-activating enzyme (SUMO-activating enzyme) (E1), with an IC50 of 0.2 μM for SUMOylation in vitro .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-124822
CAS No.: 73439-19-7
Purity:  99.73%
Target:  

AMPK

Research Areas:  

Metabolic Disease Cancer

COH-SR4 is an AMPK activator. COH-SR4 shows potent anti-proliferative activities against leukemia, melanoma, breast and lung cancers. COH-SR4 inhibits adipocyte differentiation via AMPK activation. COH-SR4 can be used for the research of obesity and related metabolic disorders .
loading...
    loading...
Cat. No.: HY-115666
CAS No.: 314248-24-3
Purity:  98.75%
Research Areas:  

Cancer

COH34 analog 1, a metabolite, is an oxidized analog of COH34. COH34 is a potent poly(ADP-ribose) glycohydrolase (PARG) inhibitor .
loading...
    loading...
Cat. No.: HY-149439
CAS No.: 20217-22-5
Purity:  99.25%
COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-184167
Research Areas:  

Cancer

COH-19 is a potent mTOR inhibitor. COH-19 binds to the ATP-binding pocket of mTOR, reduces mTOR protein levels, and suppresses the PI3K/Akt/mTOR signaling pathway. COH-19 induces apoptosis via the mitochondrial pathway. COH-19 causes G0/G1 phase cell cycle arrest and suppresses cancer cell proliferation. COH-19 can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-184166
Target:  

mTOR Apoptosis

Research Areas:  

Cancer

COH-17 is a potent mTOR inhibitor. COH-17 exhibits selective anticancer activity against breast cancer cells, showing significant anticancer effects through inhibiting mTOR, inducing apoptosis and arresting the cell cycle. COH-17 can be used for the research of breast cancer .
loading...
    loading...